Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma | Synapse
November 19, 2019
Open Access
In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma
FL
Fei Li
China Mobile (China)
QH
Qingyuan Huang
Shanghai Medical College of Fudan University
TL
Troy A. Luster
Dana-Farber Cancer Institute
See all
Key Points
Key points are not available for this paper at this time.
Abstract
.
Read Full Paper
with AI
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Li et al. (Tue,) studied this question.
synapsesocial.com/papers/6a00e873e92f4a033c85571b
https://doi.org/https://doi.org/10.1158/2159-8290.cd-19-0780